ARCHIVES

Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says.

This article is from The Cancer Letter archive.

Vol. 31 No. 45 | December 9, 2005

Download PDF Visit The Full Archive

Related Articles

ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures

March 29, 1985

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998

NCI CTEP Approved Trials For the Month of January

January 25, 2013

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH

December 12, 2014